Mycobacterium phlei F.U.36 combined with Huangqi injections for stable asthma

Abstract

Objective To investigate the efficacy of acupoint injections of mycobaoterium phlei F.U.36 combined with huangqi, and cordate houttuynia for stable. Methods 56 patients with stable asthma were randomized to receive acupoint injections of mycobacterium phlei F.U.36, huangqi, and cordatehouttuynia every the other day (study group, 32 patients), or conventional therapy (control group, 24 patients). The efficacy was observed in the two groups. The changes in FVC, FEV1, and VC were determined. Results The study group was superior to the control group in the total effective rate (96.87% vs 79.17%; x2=10, P< 0.01). VC, FVC, and FEV1 were markedly improved in the study group ([2.91 ± 0.64]vs [1.79 ± 0.43]L, P < 0.05; [2.09 ± 0.62]vs [1.64 ± 0.46]L, P< 0.05; [1.35 ± 0.35]vs [0.92 ± 0.70]L, P< 0.05); while they did not differ significantly in the control group before and after treatment (P< 0.05). Conclusions The efficacy of acupoint injections of mycobacterium phlei F.U.36, huangqi and cordate houttuynia for stable asthma is better than that of conventional therapy. Key words: Mycobacterium phlei F.U.36; Huangqi injection; Stable asthma